Peptide Research

PATH TO PEPTIDES PT-141: A DIFFERENT APPROACH TO SEXUAL HEALTH RESEARCH The first new class of sexual health compound in over 20 years works through the brain, not blood flow. Here's the science. FOR OVER TWO DECADES, EVERY SEXUAL HEALTH MEDICATION WORKED THE SAME WAY — BY INCREASING BLOOD FLOW. THEN RESEARCHERS DISCOVER...

PATH TO PEPTIDES GROWTH HORMONE PEPTIDES: WHAT THE RESEARCH SAYS CJC-1295, Ipamorelin, and the science behind the most-prescribed peptide protocols at anti-aging clinics. YOUR BODY'S NATURAL GROWTH HORMONE PRODUCTION DROPS BY ROUGHLY 14% EVERY DECADE AFTER AGE 30. BY 60, YOU'RE PRODUCING A FRACTION OF WHAT YOU DID AT 20....

PATH TO PEPTIDES "OZEMPIC BABIES": WHAT SCIENCE SAYS ABOUT GLP-1 AND FERTILITY Prescriptions for women with PCOS surged 637%. Thousands report unexpected pregnancies. Here's what researchers know so far. GLP-1 PRESCRIPTIONS FOR WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS) INCREASED 637% BETWEEN 2020 AND 2024. THOUSANDS OF...

PATH TO PEPTIDESKLOW: THE COPPER PEPTIDE SCIENCE BEHINDTHE VIRAL TREND GHK-Cu has taken over social media. But what does the actual research say about this copper peptide? YOUR BODY'S NATURAL LEVELS OF THE COPPER PEPTIDE GHK-CU DROP BY OVER 60% BY AGE 60. MEANWHILE, THE COSMETIC PEPTIDE MARKET IS SET TO HIT $8 BILLION B...

PATH TO PEPTIDES GLP-1 AND THE BRAIN CAN DIABETES DRUGS PROTECT AGAINST DEMENTIA? One study showed a 45% lower dementia risk. Then a major trial failed. The full story is more interesting than either headline. A STUDY OF OVER 100,000 PATIENTS FOUND THAT PEOPLE TAKING GLP-1 DRUGS HAD UP TO A 45% LOWER RISK OF DEVELOPING D...

PATH TO PEPTIDES GLP-1 AND YOUR HEART WHAT A 2-MILLION-PATIENT STUDY REVEALED A STUDY OF OVER 2 MILLION PATIENTS FOUND THAT GLP-1 DRUGS WERE LINKED TO LOWER RISK OF 42 DIFFERENT HEALTH CONDITIONS — INCLUDING HEART ATTACK, STROKE, AND HEART FAILURE. That's not a typo. Medications originally designed to manage blood sugar ...

PATH TO PEPTIDES GLP-1 AND YOUR HEART WHAT A 2-MILLION-PATIENT STUDY REVEALED A STUDY OF OVER 2 MILLION PATIENTS FOUND THAT GLP-1 DRUGS WERE LINKED TO LOWER RISK OF 42 DIFFERENT HEALTH CONDITIONS — INCLUDING HEART ATTACK, STROKE, AND HEART FAILURE. That's not a typo. Medications originally designed to manage blood sugar ...

PATH TO PEPTIDES BEYOND OZEMPIC THE NEXT WAVE OF WEIGHT LOSS SCIENCE THE HOOK In December 2025, a clinical trial made headlines. Participants taking a new drug called retatrutide lost an average of 71 pounds — roughly 28.7% of their body weight — in just over a year. That's nearly double what first-generation medications...

PATH TO PEPTIDES MITOCHONDRIAL PEPTIDES: THE NEXT FRONTIER IN ANTI-AGING INTRODUCTION Inside nearly every cell in your body are tiny structures called mitochondria. Think of them as cellular power plants — they convert food and oxygen into the energy your cells need to function. As we age, our mitochondria become less ef...

PATH TO PEPTIDES PEPTIDES FOR SLEEP & STRESS INTRODUCTION Sleep disorders affect approximately 50-70 million Americans, and chronic stress is reported by 77% of adults as affecting their physical health. While pharmaceutical treatments exist, researchers are investigating whether certain peptides — including DSIP, Sel...